Menu
Recruiting NCT05155878

Prognostic Factors in Periampullary Tumors and Cysts

Observational Pancreas Cancer Pancreas Neoplasm Pancreas Cyst Pancreatic Fistula

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Pancreas Cancer, Pancreas Neoplasm, Pancreas Cyst, Pancreatic Fistula. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Sweden
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Prognostic Factors, Operative Care and Short and Long Term Outcomes for Cysts and Tumors in Pancreas and the Periampullary Region

Overview

The project aims at analysing prognostic and predictive factors involved in diagnostics and surgical treatment of cysts and tumors in the pancreas and periampullary region using both clinical data and blood and tissue samples for biomarker development and validation.

Detailed description

From november 2021 an onward, study participants will be prospectively enrolled within the observational study. Before that, study participants are retrospectively enrolled. The study has a broad perspective including studies on clinical outcomes and prognostics based on patient and tumor characteristics.

Primary outcome measures

  • Overall survival [Time frame: 10 years]
Secondary outcome measures (2)
  • Complications [Time frame: 10 years]
  • Radical resection [Time frame: 10 years]

Eligibility criteria

Inclusion criteria

  • Recommended surgery for tumor or cyst in the pancreas or periampullary region
  • Information avalible in electronic journal files
  • Informed consent (or deceased for retrospective part of the study)

Exclusion criteria

  • No informed consent (and still alive at study initiation)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Sweden · 1 center
  • Surgical Clinic at Umeå University Hospital — Umeå

Identifiers

NCT: NCT05155878 · UmU-parpanc

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗